Want to see AU:BUB full AI Analyst Report?
BUB Stock Chart & Stats
AU$0.09
>-AU$0.01(-1.27%)
At close: 4:00 PM EDT
AU$0.09
>-AU$0.01(-1.27%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.17
Previous CloseN/A
Volume923.77K
Average Volume (3M)2.30M
Market Cap
AU$102.82M
Enterprise ValueAU$75.33
Total Cash (Recent Filing)AU$9.41M
Total Debt (Recent Filing)AU$15.92M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding894,130,070
10 Day Avg. Volume4,672,659
30 Day Avg. Volume2,303,075
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.76
Price to Sales (P/S)0.62
P/FCF Ratio-4.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.17Price Target Upside91.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$124.45M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue growth indicates that Bubs is expanding demand for its infant nutrition portfolio despite external headwinds. Continued top-line progress increases scale, supports broader distribution, and provides a foundation for improving operating leverage as exceptional costs normalize.
U.S. Market ExpansionThe U.S. has become Bubs’ largest growth engine, combining strong sales growth with materially broader retail distribution. Greater shelf presence across multiple formats can improve brand reach, repeat purchasing, and the durability of international revenue over coming quarters.
Underlying ProfitabilityPositive underlying EBITDA and identified cost savings suggest the core operation has earnings potential beneath reported exceptional charges. If efficiencies persist and product flows normalize, this operating improvement could support a more durable path toward reported profitability and stronger reinvestment capacity.
Bears Say
Cash GenerationDeeply negative operating and free cash flow remains a significant fundamental weakness because growth is not yet converting into internally generated liquidity. Persistent outflows can constrain investment flexibility and increase reliance on funding while the company works to stabilize operations.
Margin And Earnings VolatilityThe swing back to losses and substantial gross-margin compression demonstrate that earnings durability remains unproven. Even with management expecting normalization, weaker margins reduce the cash produced per sale and leave results more exposed to cost pressures and execution variability.
Competitive And Category PressureBubs operates in highly competitive markets where intense brand choice and declining birth rates can limit category volume growth. The sharp decline in Rest of World revenue also shows that regulatory pauses and market-specific execution issues can weaken geographic diversification.
Bubs Australia Ltd. News
BUB FAQ
What was Bubs Australia Ltd.’s price range in the past 12 months?
Bubs Australia Ltd. lowest share price was AU$0.08 and its highest was AU$0.17 in the past 12 months.
What is Bubs Australia Ltd.’s market cap?
Bubs Australia Ltd.’s market cap is AU$102.82M.
When is Bubs Australia Ltd.’s upcoming earnings report date?
Bubs Australia Ltd.’s upcoming earnings report date is Mar 01, 2027 which is in 168 days.
How were Bubs Australia Ltd.’s earnings last quarter?
Bubs Australia Ltd. released its earnings results on Aug 26, 2026. The company reported -AU$0.01 earnings per share for the quarter.
Is Bubs Australia Ltd. overvalued?
According to Wall Street analysts Bubs Australia Ltd.’s price is currently Undervalued.
Does Bubs Australia Ltd. pay dividends?
Bubs Australia Ltd. does not currently pay dividends.
What is Bubs Australia Ltd.’s EPS estimate?
Bubs Australia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bubs Australia Ltd. have?
Bubs Australia Ltd. has 894,130,070 shares outstanding.
What happened to Bubs Australia Ltd.’s price movement after its last earnings report?
Bubs Australia Ltd. reported an EPS of -AU$0.01 in its last earnings report. Following the earnings report the stock price went down -7.527%.
Which hedge fund is a major shareholder of Bubs Australia Ltd.?
Currently, no hedge funds are holding shares in AU:BUB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bubs Australia Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.17 (91.67% Upside)
AU$0.17 (91.67% Upside)
Blogger Sentiment
Neutral
AU:BUB Sentiment 55%
Sector Average 62%
Sector Average 62%
Insider Transactions
Bought Shares
Worth AU$327.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
26.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bubs Australia Ltd.
Bubs Australia Limited, together with its subsidiaries, manufactures and sell infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. The company offers goat and cow milk infant formulas, goat milk powder products for adults, and fresh dairy products. It also provides organic baby food, cereals, toddler snacks, and chilled goat milk. In addition, the company holds IP and trademarks. It sells its products under the Bubs and Caprilac brands. The company exports its products to China, Japan, Singapore, Malaysia, Vietnam, the Middle East, and North America. Bubs Australia Limited was founded in 2005 and is based in Dandenong, Australia.
BUB Stock 12 Month Forecast
Average Price Target
AU$0.17
▲(91.67% Upside)
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Nuchev Pty Ltd
―
Nutritional Growth Solutions Ltd.
―
Clover Corporation Limited
―